Germline

Gulnur Zhunussova, Nazgul Omarbayeva, Aigul Zhunussova, Diana Abdullayeva, Liliya Skvortsova, Nursultan Nurdinov, Ainash Oshibayeva

Abstract readCase Reports

PubMed Full text at PMC Publisher

In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gulnur ZhunussovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0001-8642-9577

Nazgul OmarbayevaOncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.

Aigul ZhunussovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.

Diana AbdullayevaOncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.

Liliya SkvortsovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0002-2035-2244

Nursultan NurdinovDepartment of Fundamental Medical Disciplines, Faculty of Dentistry, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan.ORCID 0000-0001-5341-7211

Ainash OshibayevaDepartment of Public Health and Scientific Research, Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan.ORCID 0000-0002-5655-5465

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24992814

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastFanconi Anemia Complementation Group N ProteinGerm-Line MutationAdultDisease ProgressionFemaleHumansKazakhstanPregnancyFanconi Anemia Complementation Group N ProteinPALB2 protein, humanaggressive disease progressionbreast cancergermline varianthereditary breast cancerKazakhstanPALB2

Identifiers

PMID42650105

DOI10.3390/genes17080913

PMCPMC13512626

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.